¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Calcium Compounds"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® calcium ÇÑ±Û Ä®½·
¼³¸í   
  ½ÅüÀÇ °ÅÀÇ ¸ðµç Á¶Á÷¿¡¼­ ¹ß°ßµÇ´Â ÀüÇØÁú·Î ¿©·¯ °¡Áö ¿ªÇÒÀ» ¸ö¿¡¼­ ´ã´çÇÑ´Ù. Áß¿äÇÑ ±â´ÉÀ» »ìÆìº¸¸é ¿ì¼± Àλê°ú °áÇÕÇÏ¿© »À³ª ÀÌ»¡À» ¸¸µå´Â ¿ªÇÒÀ» ÇÑ´Ù. ±×¸®°í ¸ðµç ±ÙÀ°ÀÇ ¼öÃà¿¡ ¾ø¾î¼­´Â ¾ÈµÉ ÀüÇØÁú·Î ÀÛ¿ëÀ» ÇÑ´Ù. Ç÷¾×ÀÀ°íÀÇ ¿©·¯ ´Ü°è¿¡µµ °ü¿©ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • coronary calcium scan
    °ü»óµ¿¸ÆÄ®½·½ºÄµ
  • calcium
    Ä®½·
  • calcium chloride
    ¿°È­Ä®½·
  • calcium ethylenediaminetetraacetic acid
    Ä®½·¿¡Æ¿·»µð¾Æ¹Î»ç¾Æ¼¼Æ®»ê
  • calcium gluconate
    ±Û·çÄÜ»êÄ®½·
  • calcium oxalate stone
    ¼ö»êÄ®½·µ¹
  • calcium phosphate stone
    ÀλêÄ®½·µ¹
  • calcium pump
    Ä®½·ÆßÇÁ
  • calcium-catalyzed reaction
    Ä®½·Ã˸ŹÝÀÀ
  • calcium-channel blocker
    Ä®½·Åë·ÎÂ÷´ÜÁ¦
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • calcium ethylenediaminetetraacetic acid
    Ä®½·¿¡Æ¿·»µð¾Æ¹Î»ç¾Æ¼¼Æ®»ê
  • calcium
    Ä®½·
  • calcium gluconate
    ±Û·çÄÜ»êÄ®½·
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • calcium
    Ä®½·
  • calcium chloride
    ¿°È­Ä®½·
  • calcium oxalate stone
    ¼ö»êÄ®½·µ¹
  • calcium phosphate stone
    ÀλêÄ®½·µ¹
  • calcium-catalyzed reaction
    Ä®½·Ã˸ŹÝÀÀ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • calcium channel blocker ; calcium channel blocking drug
    Ä®½·Åë·ÎºÀ¼â¾à ¹°<Á¦>, Ä®½·Åë·Î Â÷´Ü¾à¹°<Á¦>.
  • calcium channel blocker ; calcium channel blocking drug
    Ä®½·Åë·ÎºÀ¼â¾à¹°<Á¦>, Ä®½·Åë·ÎÂ÷´Ü¾à¹°<Á¦>.
  • carbamino compounds
    Ä«¸£¹Ù¹Ì³ë È­ÇÕ¹°.
  • organomercurial compounds
    À¯±â¼öÀºÈ­ÇÕ¹°(ËôË»ËàËô̴̰ËÑ).
  • organomercurial compounds
    À¯±â¼öÀºÈ­ÇÕ¹°(êóѦâ©ëÞûùùêÚª).
  • sulfhydryl compounds
    SH º¹ÇÕü
  • calcium
    Ä®½·
  • calcium
    Ä®½·
  • calcium alterans
    Ä®½·±³´ë( -ÎßÓÛ).
  • calcium antagonist
    Ä®½·±æÇ×Á¦.
  • calcium balance
    Ä®½·ÆòÇü(¡­øÁû¬)
  • calcium bilirubinate crystal
    ºô¸®·çºó»êÄ®½·°áÁ¤
  • calcium carbonate
    ź»êÄ®½·
  • calcium channel
    Ä®½·Åë·Î( -÷×ÖØ).
  • calcium channel
    Ä®½· Åë·Î(÷×ÖØ)
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • calcium folinate
    Ä®½·Æú¸®³×ÀÌÆ®
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • calcium
    Ä®½·
  • calcium-activated factor
    Ä®½·ºÎȰ ÀÎÀÚ(Ý·üÀì×í­)
  • calcium-activated neutral proteinase
    Ä®½·ºÎȰ(Ý·üÀ) Áß¼º(ñéàõ)ÇÁ·ÎƼ³×À̽º
  • calcium chloride transformation
    ¿°È­Ä®½· º¯Çü¼ú(ܨû¡âú)
  • calcium-dependent proteinase
    Ä®½·ÀÇÁ¸(ëîðí) ÇÁ·ÎƼ³×À̽º
  • calcium-dependent regulatory protein
    Ä®½·ÀÇÁ¸ Á¶Àý´Ü¹éÁú(ëîðíðàï½Ó±ÛÜòõ)
  • calcium phosphate gel
    Àλê(×òß«)Ä®½· Á©
  • calcium pump
    Ä®½· ÆßÇÁ
  • filtrable calcium
    °¡¿©°ú(ʦÕëΦ) Ä®½·
  • free calcium
    À¯¸®(ë´×î) Ä®½·
  • unionized calcium
    ºñ(Þª)ÀÌ¿ÂÈ­ Ä®½·
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • calcium
    Ä®½·
  • calcium, milk
    Ä®½·¿ìÀ¯
  • milk of calcium
    ¿ìÀ¯ÇüÄ®½·
  • milk of calcium bile
    ¿ìÀ¯ÇüÄ®½·´ãÁó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
'Greek letter alpha' angular acceleration; first [carbon atom next to the carbon atom bearing the active group in organic...
beta [Greek letter beta] an anomer of a carbohydrate; buffer capacity; carbon separated from a carboxyl by one other carbon i...
Ca   1) Carcinoma
  2) Cancer; ¾Ï
  3) Calcium
CPPD Calcium Pyro-Phosphate Dihydrate
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CICR Calcium Induced Calcium Release
EACs Endocrine active compounds
NOC N-Nitroso compounds
OPC Organophosphorus compounds
PAC Polycyclic aromatic compounds
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • organochloric compounds poisoning
    À¯±â ¿°¼Ò Áßµ¶
    À¯±â ¿°¼ÒÁ¦ÀÎ DDT, BHC, PCB, PCT ¶Ç´Â ¾Ëµå¸°, ¿£µå¸°, µôµå¸° µî¿¡ ÀÇÇÑ Áßµ¶. À¯±â ¿°¼ÒÁ¦´Â ÀϹÝÀûÀ¸·Î ½Ñ °ªÀ¸·Î ¾ç»êµÇ¹Ç·Î ³ó¾àÀ» ºñ·ÔÇÏ¿© »ê¾÷¿ëÀ¸·Î ³Î¸® ¾²ÀδÙ. ±×·¯³ª ÀÜÈ¿°¡ ±æ°í, ½Ä¹° ¿¬¼â¸¦ °ÅÃÄ »ç¶÷À̳ª °¡ÃàÀÇ Ã¼³»¿¡ ÃàÀûµÇ¹Ç·Î, ÀÎü¿¡¼­´Â ½Å°æ, °£ µî¿¡ À¯ÇØÇÑ ÀÛ¿ëÀ» ¹ÌÄ£´Ù.
  • sulfhydryl compounds
    SH º¹ÇÕü
  • calcium
    Ä®½·
    »ýü Áß¿¡¼­ °¡Àå ´Ù·®À¸·Î ÇÔÀ¯µÈ ¹«±â ¹°Áú. 99% ÀÌ»óÀÌ »À³ª Ä¡¾Æ µî °æÁ¶Á÷¿¡ Á¸ÀçÇÏ¸ç °ñ°ÝÀÇ À¯Áö ¹× Ä®½·ÀÇ ÀúÀå°í·Î¼­ ÀÛ¿ë. °ÅÀÇ ¸ðµç À¯±â Á¶Á÷ ³»¿¡ µé¾î ÀÖ´Â Áß¿ä ¿ø¼Ò. Ç÷¾× ÀÀ°íÀÇ ¿©·¯ ´Ü°è¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí Àֱ⠶§¹®¿¡ ÀÀ°í ÀÎÀÚ ¥³¶ó°í ºÒ·Á ¿Ô´Ù.
  • calcium balance
    Ä®½· ÆòÇü
    ü³»ÀÇ Ä®½· ³óµµ°¡ ¾ÈÁ¤µÇ¾î ÀÖ´Â »óÅÂ.
  • calcium channel
    Ä®½· ä³Î
    Ä®½·ÀÌ Åë°úÇÏ´Â µµ°ü.
  • calcium channel blocker
    Ä®½· Åë·Î ºÀ¼â ¾à¹°, Ä®½· Åë·Î Â÷´Ü ¾à¹°, Ä®½· ä³Î Â÷´ÜÁ¦
    µ¿ÀǾî=calcium channel blocking drug. 1. Ä®½·ÀÌ Åë°úÇÏ ´Â µµ°üÀ» ¸·´Â ¾à¹°. 2. Ç× Çù½ÉÁõ Á¦Á¦, Ç×°íÇ÷¾Ð Á¦Á¦, Ç× ºÎÁ¤¸Æ Á¦Á¦·Î »ç¿ëµÇ´Â ¾à¹°·Î½á, µ¿¸ÆÀÇ ÆòȰ±Ù¿¡¼­ Ä®½·ÀÇ À¯ÀÔÀ» Â÷´ÜÇÔÀ¸·Î½á ¸»ÃÊ ¼Òµ¿¸ÆÀ» ÀÌ¿ÏÇØ¼­ ½É±ÙÀÇ »ê¼Ò ¿ä±¸·®À» ÀúÇϽÃŰ´Â ±â´ÉÀ» ÇÑ´Ù. ´ëÇ¥ÀûÀÎ ¾à¹°·Î´Â, vera
  • calcium channel blocking drug
    Ä®½· Åë·Î ºÀ¼â ¾à¹°, Ä®½· Åë·Î Â÷´Ü ¾à¹°
  • calcium deposit
    ¼®È¸ Ä§Âø
    Ä¡°ú¿¡¼­ Ä¡¾Æ Ç¥¸é¿¡ Á¡ÂøµÇ¾î ÀÖ´Â °æ¼º ¶Ç´Â ¿¬¼ºÀÇ ¹°Áú.
  • calcium gluconate
    ±Û·çÄÜ »ê Ä®½·
    ±Û·çÄÜ »êÀÇ Ä®½·¿°. ¹«Ãë ¹«¹ÌÀÇ ¹é»ö °áÁ¤¼º °ú¸³ ¶Ç´Â ºÐ¸». Ä®½· º¸±Þ¿¡ Á¤Á¦ ¶Ç´Â ¾×ÀÌ »ç¿ëµÈ´Ù. ºÒÈ­¹°À̳ª ¼ö»ê Áßµ¶¿¡ ´ëÇÑ °æ±¸ ÇØµ¶Á¦ÀÌ´Ù.
  • calcium gout
    Ä®½· Åëdz
  • calcium hydroxide
    ¼ö»êÈ­ Ä®½·
    ¹é»ö ºÐ¸»·Î Á¸ÀçÇÏ´Â ¿°. ±¹¼ÒÀûÀÎ ¼ö·ÅÁ¦·Î »ç¿ëµÈ´Ù.
  • calcium hypophosphate
    Ä®½· ¾ÆÀÎ»ê ¿°
    ÆÇÅäÅÙ »êÀÇ ¿ì¼±¼º À̼ºÃ¼ÀÇ Ä®½· ¿°, B º¹ÇÕü ºñŸ¹Î. ¹é»öÀÇ ºÐ¸». ´Ù¸¥ ºñŸ¹Î B¿Í °áÇÕÇÏ¿© ¿µ¾ç °ø±Þ¿øÀ¸·Î »ç¿ëµÈ´Ù.
  • calcium levulinate
    ·¹ºÒ¸° »ê Ä®½·
    Ä®½· º¸½ÀÁ¦. ¹é»ö °áÁ¤¼º ¶Ç´Â ¹«Á¤Çü ºÐ¸¸. Ä®½· °áÇÌÁõÀÇ Ä¡·á¿¡ Ä®½· º¸±ÞÁ¦·Î »ç¿ëµÈ´Ù.
  • calcium metabolism
    Ä®½·´ë»ç
    Ç÷ÀåÁßÀÇ Ä®½· ³óµµ¸¦ ÀÏÁ¤ÇÏ°Ô À¯ÁöÇÏ¸ç »ÀÀÇ ¼®È¸È­¸¦ À§ÇÑ Ä®½· °ø±ÞÀ» ÇÏ´Â »ýÈ­ÇÐÀû, »ý¸®ÇÐÀû °úÁ¤.
  • calcium oxide
    »êÈ­ Ä®½·
    ºÎ½Ä¼º ¾ËÄ®¸®, ºÎ½Ä¼º Åä·ùÀÇ ÀÏÁ¾. °ø±âÁßÀÇ ÀÌ»êȭź¼Ò¸¦ Èí¼öÇÏ´Â µ¥ ¾²À̸ç, °ø¾÷ÀûÀ¸·Î´Â °ª½Ñ ¾ËÄ®¸®·Î ±×¸®°í ¸ð¸£Å¸¸£ÀÇ ±âÀç·Î »ç¿ëµÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
alicyclic compounds See: cyclic compound.
(05 Mar 2000)
alkylmercury compounds Organic mercury compounds in which the mercury is attached to an alkyl group.
(12 Dec 1998)
alum compounds Aluminum metal sulfate compounds used medically as astringents and for many industrial purposes. They are used in veterinary medicine for the treatment of ulcerative stomatitis, leukorrhoea, conjunctivitis, pharyngitis, metritis, and minor wounds.
(12 Dec 1998)
aluminum compounds Inorganic compounds that contain aluminum as an integral part of the molecule.
(12 Dec 1998)
aminobiphenyl compounds <chemistry> Biphenyl compounds substituted in any position by one or more amino groups. Permitted are any substituents except fused rings.
(12 Dec 1998)
ammonium compounds Inorganic and organic compounds that contain the hypothetical radical nh4.
(12 Dec 1998)
barium compounds Inorganic compounds that contain barium as an integral part of the molecule.
(12 Dec 1998)
benzalkonium compounds <chemical> A mixture of alkylbenzyldimethylammonium compounds. It is a bactericidal quaternary ammonium detergent used topically in medicaments, deodorants, mouthwashes, as a surgical antiseptic, and as a as preservative and emulsifier in drugs and cosmetics.
Pharmacological action: anti-infective agents, local, detergents, preservatives, pharmaceutical.
(12 Dec 1998)
benzhydryl compounds Compounds which contain the methyl radical substituted with two benzene rings. Permitted are any substituents, but ring fusion to any of the benzene rings is not allowed.
(12 Dec 1998)
benzylidene compounds Compounds containing the phch= radical.
(12 Dec 1998)
bephenium compounds <chemical> Analogs or derivatives of bephenium (n,n-dimethyl-n-(2-phenoxyethyl)benzenemethanaminium).
Pharmacological action: antinematodal agent.
(12 Dec 1998)
bicyclo compounds, heterocyclic A class of saturated compounds consisting of two rings only, having two or more atoms in common, containing at least one hetero atom, and that take the name of an open chain hydrocarbon containing the same total number of atoms.
(12 Dec 1998)
boron compounds Inorganic or organic compounds that contain boron as an integral part of the molecule.
(12 Dec 1998)
bridged compounds Cyclic hydrocarbons that contain multiple rings and share one or more atoms.
(12 Dec 1998)
bromine compounds Inorganic compounds that contain bromine as an integral part of the molecule.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Calcium Compounds - »õâ Inorganic compounds that contain calcium as an integral part of the molecule.
    Synonyms : Compounds, Calcium
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • calcium
    Ä®½·
  • calcium
    Ä®½·(±Ý¼Ó¿ø¼Ò,±âÈ£ Ca,¹øÈ£ 20)
  • calcium arsenate
    ºñ»êÄ®½·(»ìÃæÁ¦)
  • calcium carbide
    źȭĮ½·
  • calcium carbonate
    ź»êÄ®½·
  • calcium chloride
    ¿°È­Ä®½·
  • calcium hydroxide
    ¼ö»êÈ­Ä®½·;¼Ò¼®È¸
  • calcium light
    Ä®½·±¤(limelight)
  • calcium oxide
    »êÈ­Ä®½·;»ý¼®È¸
  • calcium phosphate
    ÀλêÄ®½·
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á